Perfectly timed announcement with his perfectly timed sell of stock.
“ His stock sale was carried out at $41.94 a share. The 52-week-high for Pfizer stock is $41.99…”
His stock sale was carried out through a routine Rule 10b5-1, a predetermined trading plan that allows company staff members to sell their stock in line with insider-trading laws. Bourla’s sale was part of a plan adopted August 19.
Pfizer confirmed that Bourla’s stock sales were part of a plan that allows major shareholders and insiders of exchange-listed corporations to trade a predetermined number of shares at an agreed time.
“Through our stock plan administrator, Dr. Bourla authorized the sale of these shares on August 19, 2020, provided the stock was at least at a certain price,” a Pfizer spokesperson told Business Insider.
Rule 10b5-1 是没有问题，有嫌疑的是他选择这个日期发布是不是因为自己的10b5-1之前定在了这天。不过我倾向于没啥大关系，真要操作的话不会刻意选同一天吧。事实上Pfizer股价变动也不大
其实CEO买股票是很正常的事情 大概率是提前就schedule好的 MRNA的管理层也一直在卖股票 最主要是看CEO这个filing是在知道疫苗消息之前还是之后